Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial-Reference-Cited by-同舟云学术

Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial

Published:2017-02 Issue:1 Volume:15 Page:42-52.e8
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Vogelzang Nicholas J.,Coleman Robert E.,Michalski Jeff M.,Nilsson Sten,O'Sullivan Joe M.,Parker Christopher,Widmark Anders,Thuresson Marcus,Xu Lei,Germino Joseph,Sartor Oliver

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference30 articles.

1. Managing bone metastases and reducing skeletal related events in prostate cancer;Gartrell;Nat Rev Clin Oncol,2014

2. Management of bone metastases in patients with castration-resistant prostate cancer;Cathomas;Urol Int,2014

3. Practical guide to bone health in the spectrum of advanced prostate cancer;Butoescu;Can J Urol,2014

4. Burden of skeletal-related events in prostate cancer: unmet need in pain improvement;Broder;Support Care Cancer,2015

5. Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases;Nieder;BMC Cancer,2010

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative single-photon emission computed tomography/computed tomography in assessing the effectiveness of radium-223 dichloride therapy;Cancer Urology;2024-08-15

2. Elevated Baseline Mean Corpuscular Volume Predicts the Development of Severe Hematologic Toxicity After¹⁷⁷Lu-DOTATATE Therapy;Journal of Nuclear Medicine;2024-07-11

3. Targeted Radiopharmaceutical Therapy for Bone Metastases;Seminars in Nuclear Medicine;2024-07

4. Safety and effectiveness of the radium‐223–taxane treatment sequence in patients with metastatic castration‐resistant prostate cancer in a global observational study (REASSURE);Cancer;2024-02-10

5. The Bone Pathway: 223Ra-Dichloride;Radiopharmaceuticals;2024